T he arterial endothelium survives remarkably well as the interface between blood and vessel wall in an environment of constantly changing biomechanical stresses as well as acute and chronic exposure to inflammatory stimulants (eg, cytokines and hypercholesterolemia respectively). 1 Cell turnover, which tends to occur in regional clusters, 2 is otherwise very low in this monolayer. The endothelium also plays an important regulatory role in the pathogenesis of vascular disease. The cells readily respond to diverse stimuli through a repertoire of mechanisms to enhance their own survival even as they facilitate inflammatory, proatherogenic responses in the subendothelial tissue. The necessity to be a responsive cellular interface probably accounts for much of the endothelial phenotype heterogeneity that exists between vascular beds as well as within discrete regions of the arterial circulation. 3, 4 Hemodynamic characteristics that vary with blood vessel geometry predict the location of arterial sites that are susceptible to atherosclerosis. 5 Curved and branching vessel geometries create sites of flow separation that contain transient flow reversals, lower average shear stresses, and occasional turbulence, (collectively, disturbed flow) and that are predictive of lesion formation. In contrast, pulsatile unidirectional laminar flow (and higher average shear stresses) is associated with regions where atherosclerosis rarely occurs, despite there being equivalent exposure to plasma risk factors such as hypercholesterolemia throughout the circulation. Although the signatures of endothelial phenotype in such regions in vivo are varied and complex, data are emerging from genomic [5] [6] [7] and protein 8 analyses of endothelium at such sites that identify molecular differences. Some of these are accessible for study in vitro to investigate detailed mechanisms under more controlled conditions. An interesting example that addresses mechanisms of flow-related differential regulation of endothelial cell phenotype leading to cell survival is reported in this issue of Circulation Research.
Garin et al 9 demonstrate that the introduction of undisturbed laminar flow in vitro protects endothelial cells from tumor necrosis factor (TNF)-␣-induced apoptosis through inhibition of a pathway that cleaves protein kinase C zeta (PKC), one of several PKC isoforms expressed by the endothelium. Flow promoted cell survival instead of programmed cell death when compared with control cells not exposed to flow. The study extends previous demonstrations of flow inhibition of TNF-␣ signaling, apoptosis, and adhesion protein expression in endothelial cells 10 -12 by clarifying the role of PKC cleavage in TNF-␣-induced caspase 3 activation.
The PKC families of enzymes are serine/threonine kinases that phosphorylate effector proteins leading to multiple outcomes. PKC, a member of the atypical family of PKC enzymes, has acquired particular significance in endothelial biology. In earlier studies of cytokine-mediated apoptosis, Rahman et al (1999) 13 had demonstrated that TNF-␣-induced activation of NF-B leading to proinflammatory ICAM-1 expression is mediated through the generation of reactive oxidants controlled by an atypical PKC family isoform, (subsequently identified as PKC). 14 Other studies have since shown that adhesion molecule expression results from prolonged exposure to disturbed flow in vitro and is associated with disturbed flow in vivo. 15 Recently, Magid, and Davies 8 identified differential post-translational modification of PKC in endothelial lysates isolated from a disturbed flow region of swine aorta when compared with undisturbed flow regions in the same animals. PKC was shown to account entirely for the increased endothelial PKC enzyme activity in the athero-susceptible, disturbed flow region. In exploring a central role for PKC in flow-regulation of cytokine-activated endothelial signaling under controlled conditions in the present study, Garin et al first showed that PKC is necessary for JNK activation by TNF-␣ and that JNK in turn mediates caspase-3 activation (see Figure, panel A) . In HeLa cells, TNF-␣ induces PKC processing to a shorter highly active catalytic domain, CAT, by removal of an auto-inhibitory sequence. 16 In endothelium, CAT, generated by caspase-3 cleavage of PKC, potentiates a feedback loop that activates JNK to amplify caspase-3 activation and the cleavage of more PKC. The same pathway was shown to be present in endothelial cell fractions from rabbit aorta. Thus PKC with its internal amplification loop operates at multiple levels directed to apoptosis. The experiments revealed, however, that exposure to unidirectional laminar flow (athero-protective hemodynamics) inhibited the JNK-caspase-3-CAT generation (box in Figure, panel A) reducing or preventing apoptosis and pro-inflammatory endothelial adhesion protein expression. The implication is that regions of undisturbed laminar flow in vivo protect the endothelium via these mechanisms. The interpretation is consistent with elevated PKC activity noted in vivo in regions susceptible to atherogenesis when com-
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pared with protected regions where undisturbed flow dominates. 8 Increased phosphorylation of the activation loop at Thr410, which confers increased catalytic activity 17 and which was differentially measured at the arterial sites (see Figure, panel B) is consistent with a proinflammatory signature of flow-mediated PKC involvement in vivo when the flow is disturbed but not when the flow is unidirectional and undisturbed. The report is an interesting contribution to the interplay between cytokine-mediated and flow-mediated endothelial signaling and phenotype, and it raises several additional considerations.
Cell culture studies can be extended to create a stronger link between flow in vitro and in vivo. The flow comparison in this study uses no-flow as a reference control. In vivo in humans, arterial flow is zero only for a brief moment when the flow reverses in a region of flow separation (disturbed flow); otherwise flow is accelerating or decelerating with approx 2Hz frequency at these sites and in most other locations (where the flow is undisturbed) it is unidirectional and pulsatile. The addition of cells subjected to disturbed flow would be an important reference group for in vitro studies and may provide further insights into athero-susceptible flow. The unidirectional steady laminar flow shown to inhibit PKC cleavage could also readily be replaced by a pulsatile waveform of unidirectional flow that more closely simulates flow in athero-protected regions in vivo. However, even in present form, the experiments remain a convincing proof-of-principle demonstration of flow-mediation of an important amplification pathway.
It is unclear how flow inhibits this signaling cascade. Flow effects generally fall into two broad mechanisms; deformation forces that modify the mechanotransduction responses of the cell, and changes of convective transport within the cell and/or at the cell surface. Either or both may be relevant to PKC signaling. In the study by Rahman et al 13 In summary, mechanisms for the transduction and amplification of apoptotic signals involving PKC enzymes in tandem with caspases play an important role in a variety of cells. In the endothelium, flow-inhibition of PKC processing is an important, although not exclusive, prosurvival mechanism. In vivo measurements of endothelial PKC in the arterial circulation are consistent with differential protective mechanisms linked to hemodynamic characteristics.
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